Indietro
OFEV caps moll 150 mg
Boehringer Ingelheim (Schweiz) GmbH
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | |
|---|---|---|---|---|---|---|
OFEV caps moll 150 mg 60 pceBoehringer Ingelheim (Schweiz) GmbH | 6441923 | CHF 1577.15 | Cat. B | SLPlus / 40% |
Articoli alternativi senza carenza di approvvigionamento segnalata
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | Relazione farmaceutica | |
|---|---|---|---|---|---|---|---|
NINTEDANIB Sandoz caps moll 150 mg 60 pceSandoz Pharmaceuticals AG | 1151649 | CHF 665.40 | Cat. B | SL / 10% | Equivalente | ||
NINTEDANIB Zentiva caps moll 150 mg 60 pceHelvepharm AG | 1153771 | CHF 355.15 | Cat. B | SL / 10% | Equivalente | ||
NINTEDANIB Mepha caps moll 150 mg 60 pceMepha Pharma AG | 1156008 | CHF 665.40 | Cat. B | SL / 10% | Equivalente | ||
NINTEDANIB Spirig HC caps moll 150 mg 60 pceSpirig HealthCare AG | 1154873 | CHF 665.40 | Cat. B | SL / 10% | Equivalente | ||
OFEV caps moll 100 mg 60 pceBoehringer Ingelheim (Schweiz) GmbH | 6441917 | CHF 1576.75 | Cat. B | SLPlus / 40% | Forma | ||
NINTEDANIB Sandoz caps moll 100 mg 60 pceSandoz Pharmaceuticals AG | 1151648 | CHF 656.65 | Cat. B | SL / 10% | Forma | ||
NINTEDANIB Zentiva caps moll 100 mg 60 pceHelvepharm AG | 1153769 | CHF 330.85 | Cat. B | SL / 10% | Forma | ||
NINTEDANIB Mepha caps moll 100 mg 60 pceMepha Pharma AG | 1156006 | CHF 656.60 | Cat. B | SL / 10% | Forma | ||
NINTEDANIB Spirig HC caps moll 100 mg 60 pceSpirig HealthCare AG | 1154871 | CHF 656.65 | Cat. B | SL / 10% | Forma |